Stock Events

Stock Events

Crism Therapeutics 

GBX12.02
31
-GBX1.36-10.16% Friday 15:24

Statistics

Day High
14
Day Low
12
52W High
24.8
52W Low
8
Volume
407,495
Avg. Volume
-
Mkt Cap
4.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jun 23
GBX288
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12JunExpected
Q4 0
Q2 2020
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Next
-0.59
-0.26
0.08
0.41
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-96.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRTX.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vale.
VALE
Mkt Cap77.61B
Vale S.A. is one of the world's largest mining companies, involved in the extraction of iron ore and nickel, making it a direct competitor in the global nickel market.
BHP Group Limited
BHP
Mkt Cap204.37B
BHP is a leading global resources company that mines metals including nickel, competing with Amur Minerals in the nickel supply sector.
Teck Resources
TECK
Mkt Cap29.09B
Teck Resources is a diversified resource company, with operations and projects in the copper, zinc, steelmaking coal, and energy sectors, and competes indirectly in the metals market.
Rio Tinto
RIO
Mkt Cap162.86B
Rio Tinto is a global mining group that focuses on finding, mining, and processing mineral resources, including nickel, making it a competitor.
Lundin Mining
LUNMF
Mkt Cap25.19B
Lundin Mining is a diversified Canadian base metals mining company with operations in Brazil, Chile, Portugal, Sweden, and the United States, indirectly competing in the nickel and other metals market.

About

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
Show more...
CEO
Mr. Andrew Webb
Country
Virgin Islands (British)
ISIN
VGG042401262

Listings

STU
DE
A7L.STU
LSE
GB
CRTX.LSE

0 Comments

Share your thoughts

FAQ

What is Crism Therapeutics stock price today?▼
The current price of CRTX.LSE is GBX12.02 GBX — it has decreased by -10.16% in the past 24 hours. Watch Crism Therapeutics stock price performance more closely on the chart.
What is Crism Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Crism Therapeutics stocks are traded under the ticker CRTX.LSE.
Is Crism Therapeutics stock price growing?▼
CRTX.LSE stock has fallen by -1.47% compared to the previous week, the month change is a +6.75% rise, over the last year Crism Therapeutics has showed a +47.85% increase.
What is Crism Therapeutics market cap?▼
Today Crism Therapeutics has the market capitalization of 4.73M
When is the next Crism Therapeutics earnings date?▼
Crism Therapeutics is going to release the next earnings report on June 12, 2026.
What is Crism Therapeutics revenue for the last year?▼
Crism Therapeutics revenue for the last year amounts to 0 GBX.
What is Crism Therapeutics net income for the last year?▼
CRTX.LSE net income for the last year is -96.97M GBX.
Does Crism Therapeutics pay dividends?▼
Yes, CRTX.LSE dividends are paid en. The last dividend per share was 288 GBX. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Crism Therapeutics located?▼
Crism Therapeutics operates in the Health & Wellness sector.
When did Crism Therapeutics complete a stock split?▼
The last stock split for Crism Therapeutics was on May 31, 2024 with a ratio of 1:160.
Where is Crism Therapeutics headquartered?▼
Crism Therapeutics is headquartered in Road Town, Virgin Islands (British).